LEADING EDGE BIO

There are stark differences between the two years that saw the highed number of new molecular entities approved by the FDA, 1996 and 2014....

Google Shifts Investment towards HealthCare The graph above from the Wall Street Journal speaks for itself. Google, one of the most...

There has been much recent debate around the high price of Sovaldi, Gilead's effective cure for Hep C. Some argue that payers and...